In general, Treatment with inhaled β2-agnosits, anticholinergics and steroids decrease the level of pro-inflammatory cytokines (IL-8, IL-17 and TNF-α) in COPD patients [67, 68]. Here, TNF is linked to chronic obstructive pulmonary disease.